News


The Weinberg Group CEO to Speak at AIPPI’s International Convention on the Economy of Innovation

  • April 17, 2018
  • |

WASHINGTON, DC – April 17, 2018 – Matthew Weinberg, Chief Executive Officer of The Weinberg Group Inc., will be speaking at the International Association for the Protection of Intellectual Property’s (AIPPI’s) third International Convention on The Economy of Innovation on April 30, 2018. Mr. Weinberg’s speech will be focused on the pharmaceutical industry in the […] READ MORE...


The Weinberg Group Donates to 21 Charities in Celebration of Giving Tuesday

  • December 1, 2017
  • |

WASHINGTON, DC – November 30, 2017 – The Weinberg Group Inc., a Washington, DC, based FDA consulting firm, today released a list of 21 charitable organizations that the firm contributed to on November 28, 2017, or “Giving Tuesday.”  The charities that received donations were chosen completely by the firm’s employees. Every year The Weinberg Group […] READ MORE...


With Help of DC-Based FDA Consulting Firm, Baltimore Nonprofit Helps Minority Students Achieve Careers in STEM Fields

  • July 26, 2017
  • |

WASHINGTON, DC – July 26, 2017 – Building STEPS, a Baltimore-based nonprofit that helps minority and underprivileged high school students pursue careers in the fields of science and technology, was featured by The Baltimore Sun in an article published on July 21, 2017. The article highlights the organization’s college access program, which “recruits high school […] READ MORE...


We Are Growing…

  • December 2, 2015
  • |

The Weinberg Group, the leading FDA consultancy, is excited to announce the addition of Paul Eichholz to our leadership team.  As Senior Vice President, Quality and Compliance, with oversight of all quality services including: GMP, GCP, GLP, REMS auditing, mock FDA inspections, and the assessment and implementation of quality systems, Paul is an excellent addition […] READ MORE...


Steve Jensen Joins The Weinberg Group

  • February 3, 2015
  • |

The Weinberg Group, the leading FDA consulting firm, is pleased to announce that Steve Jensen has joined us as Senior Vice President, Head of Regulatory Consulting. Steve has over 20 years of industry experience including executive roles at Iroko, Verus and SkyePharma. He has had responsibility for products under development and launch, including managing multiple […] READ MORE...


Matthew Weinberg Quoted in Article about EMA’s Initiative to Broaden Expert Involvement with Updated Policy on Conflicts of Interest

  • November 25, 2014
  • |

FDANews Drug Industry Daily Nov. 21, 2014 Europe’s drug regulatory agency has revised the conflict of interest policy for its scientific committee members and experts, a move that one attorney says recognizes the reality that most knowledgeable specialists have at least some commercial involvement. The updated document, released by the European Medicines Agency last week, […] READ MORE...


Matthew Weinberg Writes for Tobacco Reporter

  • June 17, 2014
  • |

CEO Matthew Weinberg writes for Tobacco Reporter Magazine encouraging stakeholders to take advantage of the opportunity to respond to FDA e-cigarette regulations. READ MORE...


Drug Companies Face Stricter Clinical Trial Regulation Worldwide

  • February 11, 2014
  • |

For more information on The Weinberg Group’s independent clinical auditing services, please contact Jeff Antos at jeff.antos@weinberggroup.com or 202.280.0815. READ MORE...


Matthew Weinberg Writes for International Clinical Trials (ICT) Magazine

  • August 16, 2013
  • |

In this article CEO Matthew Weinberg discusses the downsides to self-auditing good clinical practice and the need smaller, more proactive audits, on the other hand, can provide a more intelligent analysis. READ MORE...


FDA Hears Recommendations on Updating Trial Regs

  • June 5, 2012
  • |

The June 2012 issue of the Journal of Clinical Research Best Practices covered CEO Matthew Weinberg’s presentation at the April 23 FDA clinical trials hearing. The article, entitled “FDA Hears Recommendations on Updating Trial Regs,” focused on Weinberg’s emphasis on the importance of independent clinical trial auditing. For more information on The Weinberg Group’s independent […] READ MORE...